Add Yahoo as a preferred source to see more of our stories on Google. Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...

Oct. 3, 2024 -- Respiratory Syncytial Virus (RSV) is often thought of as a childhood illness, but it poses a significant threat to older adults as well. According to the CDC, RSV infected ...

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged 60 and older, with approximately 75% effectiveness against RSV-associated ...

Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

The American Academy of Pediatrics generally recommends RSV immunization for infants under eight months old born during or entering their first RSV season if their mothers weren’t vaccinated during ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) vaccine, a new study finds. The report also showed that people in long-term ...

(StatePoint) Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to respiratory syncytial virus (RSV). RSV is a highly contagious virus ...

The UK Health Security Agency (UKHSA) has reported that the respiratory syncytial virus (RSV) vaccine is around 82% effective in preventing hospitalisation among adults aged 75-79. The data come from ...

—These investigators found that during a recent winter in England, symptoms and outcomes among older patients with RSV mimicked those seen with influenza. A new hospital-based surveillance study from ...

Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible recipients plan to get an RSV vaccine, according to a survey conducted in ...